NEW YORK, Jan. 21, 2026 /PRNewswire/ — Aidoc, the pioneer and global leader of clinical AI, today announced that the U.S. Food and Drug Administration (FDA) has cleared the healthcare industry’s first comprehensive AI triage solution^[1],[2], enabling health systems to surface critical findings earlier and reduce delays in patient flow amid Emergency Department (ED) crowding and imaging backlogs. This breakthrough was made possible by CARE™, Aidoc’s self-developed AI foundation model. The solution brings 11 newly cleared indications and three previously cleared indications together into a single workflow, enabling triage of a wide range of acute findings during high clinical demand.

EDs face sustained pressure as patient volumes rise and imaging backlogs grow, contributing to delays and crowding. With ED imaging typically read first-in, first-out, Aidoc’s shift to comprehensive triage of abdomen CT provides a safety net that surfaces acute findings earlier, supporting timely clinical decision-making and improving patient flow.